Literature DB >> 26123123

Needs and priorities of women with endometrial and cervical cancer.

Mette Moustgaard Jeppesen1, Ole Mogensen1, Pernille Dehn1, Pernille Tine Jensen1.   

Abstract

INTRODUCTION: Rehabilitation after cancer is important, and efficient rehabilitation requires knowledge of patient's needs. This study aimed to identify short-term rehabilitation needs of women with endometrial and cervical cancer.
METHODS: Ninety-six women (82.6%) were included in an exploratory questionnaire study from Odense University Hospital from September 2011 to March 2012. Needs were assessed pre-treatment and 3 months later using the three-levels-of-needs questionnaire. Furthermore, 16 women participated in focus group interviews following the treatment. The interviews were audio-recorded, transcribed verbatim and analyzed thematically.
RESULTS: Forty-four of the included women were diagnosed with cervical cancer (median age 45 years). Of these, 22 had FIGO-stage 1 disease (50%) and 23 received radiation therapy (52.3%). The remaining 52 women (median age 66.5 years) were diagnosed with endometrial cancer. Of these, 38 had FIGO-stage 1 disease (73.1%) and 25 were treated with laparoscopic surgery (48.1%). Emotional functioning was significantly worse prior to treatment in both the cancers (p < 0.001 cervical and p = 0.002 endometrial) and worry constituted an unmet need in 70.7% of cervical and 34.7% of endometrial cancer patients. Both the patient groups experienced significant lymphedema post-treatment [endometrial cancer (p = 0.006) and cervical cancer (p = 0.002)]. Further, urological problems were more prevalent post-treatment in endometrial cancer patients (p = 0.018), while sexual problems were of specific concern for cervical cancer patients (p = 0.029). However, in both cancer groups, the mean problem intensity scores were comparable to normative data, suggesting that the majority of patients will not require extensive rehabilitation. Qualitative analysis indicated that treatment modality and marital status severely impacted on coping, suggesting that irradiated and single women are at higher risk of developing rehabilitation needs. Additionally, women younger than 55 years more often requested help dealing with sexual and psychological complications. DISCUSSION: Women with endometrial and cervical cancer experience emotional problems prior to therapy and lymphedema, and urological and sexual problems following treatment. An awareness of these problems may facilitate early identification of women with unmet needs and enable individualized follow-up adjusted for such patient's needs. Interventions aimed at improving sexual and psychological functioning should be available.

Entities:  

Keywords:  Depression and anxiety in oncology patients; psycho-oncology; psychosomatic gynecology; quality of life; sexual health

Mesh:

Year:  2015        PMID: 26123123     DOI: 10.3109/0167482X.2015.1059417

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  10 in total

1.  Screening for sexual health concerns in survivors of gynecological cancer.

Authors:  Karen Roberts; Travis Chong; Emma Hollands; Jason Tan; Ganendra Raj Kader Ali Mohan; Paul A Cohen
Journal:  Support Care Cancer       Date:  2019-05-18       Impact factor: 3.603

2.  Factors related to changes in resilience and distress in women with endometrial cancer.

Authors:  Yi-Lin Chang; Chi-Mu Chuang; Ching-Hui Chien; Xuan-Yi Huang; Shu-Yuan Liang; Chieh-Yu Liu
Journal:  Arch Womens Ment Health       Date:  2020-11-07       Impact factor: 3.633

3.  Psychological impact of fertility preservation techniques in women with gynaecological cancer.

Authors:  Antonio Simone Laganà; Valentina Lucia La Rosa; Agnese Maria Chiara Rapisarda; Alessio Platania; Salvatore Giovanni Vitale
Journal:  Ecancermedicalscience       Date:  2017-02-08

4.  Perceived utility of an integrated psychological intervention for gynaecological cancer patients admitted for surgery: preliminary data.

Authors:  Paola Arnaboldi; Serena Oliveri; Valeria Vadilonga; Luigi Santoro; Angelo Maggioni; Gabriella Pravettoni
Journal:  Ecancermedicalscience       Date:  2017-02-23

5.  Psychiatric comorbidities among endometrial cancer survivors in South Korea: a nationwide population-based, longitudinal study.

Authors:  Jaesung Heo; Mison Chun; Young Taek Oh; O Kyu Noh
Journal:  J Gynecol Oncol       Date:  2018-11-07       Impact factor: 4.401

6.  Clinical and Psychological Outcomes of the Use of Vaginal Dilators After Gynaecological Brachytherapy: a Randomized Clinical Trial.

Authors:  Taís Marques Cerentini; Júlia Schlöttgen; Patrícia Viana da Rosa; Valentina Lucia La Rosa; Salvatore Giovanni Vitale; Pierluigi Giampaolino; Gaetano Valenti; Stefano Cianci; Fabrício Edler Macagnan
Journal:  Adv Ther       Date:  2019-06-17       Impact factor: 3.845

7.  The Importance of Fertility Preservation Counseling in Patients with Gynecologic Cancer.

Authors:  Salvatore Giovanni Vitale; Valentina Lucia La Rosa; Agnese Maria Chiara Rapisarda; Antonio Simone Laganà
Journal:  J Reprod Infertil       Date:  2017 Apr-Jun

Review 8.  Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach.

Authors:  Valentina Lucia La Rosa; Simone Garzon; Giuseppe Gullo; Michele Fichera; Giovanni Sisti; Pasquale Gallo; Gaetano Riemma; Antonio Schiattarella
Journal:  Ecancermedicalscience       Date:  2020-05-06

9.  Unmet Supportive Care Needs Among Women With Breast and Gynecological Cancer: Relevance of Attachment Anxiety and Psychological Distress.

Authors:  Johanna Graf; Florian Junne; Johannes C Ehrenthal; Norbert Schäffeler; Juliane Schwille-Kiuntke; Andreas Stengel; Anja Mehnert-Theuerkauf; Lennart Marwedel; Sara Y Brucker; Stephan Zipfel; Martin Teufel
Journal:  Front Psychol       Date:  2020-10-21

Review 10.  Preoperative assessment of endometrial cancer.

Authors:  Péter Török; Zoárd Krasznai; Szabolcs Molnár; Rudolf Lampé; Attila Jakab
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.